The application of imaging biomarkers has provided new insights into the mechanisms of damage in multiple sclerosis (MS) and the risk of MS development and progression. The goal of eliminating all disease activity requires a timely escalation of treatment. This increasing complexity is compounded by the need to treat comorbidities.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy
Scientific Reports Open Access 05 October 2018
-
Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model
Scientific Reports Open Access 31 January 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Freeman, L. et al. The neuronal component of gray matter damage in multiple sclerosis: a [11C]flumazenil positron emission tomography study. Ann. Neurol. 78, 554–567 (2015).
Louapre, C. et al. Beyond focal cortical lesions in MS: an in vivo quantitative and spatial imaging study at 7T. Neurology 85, 1702–1709 (2015).
Salvetti, M. et al. Progressive MS: from pathophysiology to drug discovery. Mult. Scler. 21, 1376–1384 (2015).
Tintore, M. et al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 138, 1863–1874 (2015).
De Stefano, N. et al. Long-term assessment of no evidence of disease activity in relapsing–remitting MS. Neurology 85, 1722–1723 (2015).
Kalincik, T. et al. Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis. Ann. Neurol. 77, 425–435 (2015).
Clanet, M. C. et al. Risk evaluation and monitoring in multiple sclerosis therapeutics. Mult. Scler. 20, 1306–1311 (2014).
Marrie, R. A. et al. Effect of comorbidity on mortality in multiple sclerosis. Neurology 85, 240–247 (2015).
Marrie, R. A. et al. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 72, 117–124 (2009).
Marrie, R. A. et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult. Scler. 21, 263–281 (2015).
Acknowledgements
The NMR Unit and its staff are supported by the UK Multiple Sclerosis Society, National Institute for Health Research University College London Hospitals–University College London Biomedical Research Centre, the Engineering and Physical Sciences Research Council, and University College London internal funding schemes.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.T. has received honoraria and support for travel for consultancy from Biogen Idec, Eisai, Genzyme, Novartis and Medday, and for speaking from EXCEMED, Novartis, Remedica and Teva. He receives an honorarium from Sage Publications as Editor-in-Chief of Multiple Sclerosis Journal. O.C. serves as a consultant for Biogen, GE Healthcare and Novartis, and payments are made to the institution; she receives an honorarium as Associate Editor of Neurology.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Ciccarelli, O., Thompson, A. Managing the complexity of multiple sclerosis. Nat Rev Neurol 12, 70–72 (2016). https://doi.org/10.1038/nrneurol.2016.2
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2016.2
This article is cited by
-
Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy
Scientific Reports (2018)
-
Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model
Scientific Reports (2017)
-
MiR-30a Positively Regulates the Inflammatory Response of Microglia in Experimental Autoimmune Encephalomyelitis
Neuroscience Bulletin (2017)